405 related articles for article (PubMed ID: 24252386)
1. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
[TBL] [Abstract][Full Text] [Related]
2. Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation.
Xu C; Sakai N; Taniike M; Inui K; Ozono K
J Hum Genet; 2006; 51(6):548-554. PubMed ID: 16607461
[TBL] [Abstract][Full Text] [Related]
3. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
Shin D; Feltri ML; Wrabetz L
J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease.
Tappino B; Biancheri R; Mort M; Regis S; Corsolini F; Rossi A; Stroppiano M; Lualdi S; Fiumara A; Bembi B; Di Rocco M; Cooper DN; Filocamo M
Hum Mutat; 2010 Dec; 31(12):E1894-914. PubMed ID: 20886637
[TBL] [Abstract][Full Text] [Related]
5. Four novel GALC gene mutations in two Chinese patients with Krabbe disease.
Yang Y; Ren X; Xu Q; Wang C; Liu H; He X
Gene; 2013 May; 519(2):381-4. PubMed ID: 23462331
[TBL] [Abstract][Full Text] [Related]
6. Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients.
Furuya H; Kukita Y; Nagano S; Sakai Y; Yamashita Y; Fukuyama H; Inatomi Y; Saito Y; Koike R; Tsuji S; Fukumaki Y; Hayashi K; Kobayashi T
Hum Genet; 1997 Sep; 100(3-4):450-6. PubMed ID: 9272171
[TBL] [Abstract][Full Text] [Related]
7. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
[TBL] [Abstract][Full Text] [Related]
8. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
[TBL] [Abstract][Full Text] [Related]
9. GALC mutations in Chinese patients with late-onset Krabbe disease: a case report.
Zhuang S; Kong L; Li C; Chen L; Zhang T
BMC Neurol; 2019 Jun; 19(1):122. PubMed ID: 31185936
[TBL] [Abstract][Full Text] [Related]
10. Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.
Potter GB; Santos M; Davisson MT; Rowitch DH; Marks DL; Bongarzone ER; Petryniak MA
Hum Mol Genet; 2013 Sep; 22(17):3397-414. PubMed ID: 23620143
[TBL] [Abstract][Full Text] [Related]
11. Generation of a mouse with low galactocerebrosidase activity by gene targeting: a new model of globoid cell leukodystrophy (Krabbe disease).
Luzi P; Rafi MA; Zaka M; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2001 Jul; 73(3):211-23. PubMed ID: 11461188
[TBL] [Abstract][Full Text] [Related]
12. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease.
Rafi MA; Luzi P; Chen YQ; Wenger DA
Hum Mol Genet; 1995 Aug; 4(8):1285-9. PubMed ID: 7581365
[TBL] [Abstract][Full Text] [Related]
13. Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations.
Hossain MA; Higaki K; Saito S; Ohno K; Sakuraba H; Nanba E; Suzuki Y; Ozono K; Sakai N
J Hum Genet; 2015 Sep; 60(9):539-45. PubMed ID: 26108143
[TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity of Krabbe disease.
Fu L; Inui K; Nishigaki T; Tatsumi N; Tsukamoto H; Kokubu C; Muramatsu T; Okada S
J Inherit Metab Dis; 1999 Apr; 22(2):155-62. PubMed ID: 10234611
[TBL] [Abstract][Full Text] [Related]
15. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular report of novel GALC mutations in Moroccan patient with Krabbe disease: case report.
Zerkaoui M; Ratbi I; Castellotti B; Gellera C; Lyahyai J; Kriouile Y; Sefiani A
BMC Pediatr; 2015 Nov; 15():182. PubMed ID: 26567009
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.
Lee WC; Kang D; Causevic E; Herdt AR; Eckman EA; Eckman CB
J Neurosci; 2010 Apr; 30(16):5489-97. PubMed ID: 20410102
[TBL] [Abstract][Full Text] [Related]
18. Insights into the Pathogenesis and Treatment of Krabbe Disease.
Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
[TBL] [Abstract][Full Text] [Related]
19. A new compound heterozygous mutation in adult-onset Krabbe disease.
Meng X; Li Y; Lian Y; Li Y; Du L; Xie N; Wang C
Int J Neurosci; 2020 Dec; 130(12):1267-1271. PubMed ID: 32064984
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
